Lobbying Activity Report

2603-42763

Organization: Sandoz Canada Inc.
Associated registration: 2015-2603-19
Lobbying Activity date: 2025-05-23
Arranged a meeting: Yes
Posted date: 2025-05-27

In-house lobbyists who participated in the lobbying activity: Guillaume Lefevre
Catherine Rousseau
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services & Evaluation
Pharmaceutical, Laboratory & Blood Services Division, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director, Therapeutic Assessment&Access
PharmaCare Benefits Branch, Provincial Health Services Authority

Ian Rongve, ADM
Strategic Innovation, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Improve regulatory environment and utilization rates for generics and biosimilars.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Finances and Budgets, Health
 
Senior officer who filed this Lobbying Activity Report: Michel Robidoux
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: